301
Participants
Start Date
October 30, 2006
Primary Completion Date
March 5, 2008
Study Completion Date
March 5, 2008
rosiglitazone
Tablets, 4 mg once or twice daily.
inhaled human insulin
Treat-to-target dose titration scheme, inhalation.
metformin
Tablets, 2000 mg/day.
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Ebreichsdorf
Novo Nordisk Investigational Site, Interlaken-Unterseen
Novo Nordisk Investigational Site, Olten
Novo Nordisk Investigational Site, Zurich
Novo Nordisk Investigational Site, Narbonne
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, La Rochelle
Novo Nordisk Investigational Site, Kutenholz-Mulsum
Novo Nordisk Investigational Site, Majadahonda
Novo Nordisk Investigational Site, Gijón
Novo Nordisk Investigational Site, Pessac
Novo Nordisk Investigational Site, Fulda
Novo Nordisk Investigational Site, Pontevedra
Novo Nordisk Investigational Site, Tours
Novo Nordisk Investigational Site, Genthin
Novo Nordisk Investigational Site, Seville
Novo Nordisk Investigational Site, Dormagen
Novo Nordisk Investigational Site, Reus
Novo Nordisk Investigational Site, Alzira
Novo Nordisk Investigational Site, Duisburg
Novo Nordisk Investigational Site, Münster
Novo Nordisk Investigational Site, Nevers
Novo Nordisk Investigational Site, Roubaix
Novo Nordisk Investigational Site, Frankfurt
Novo Nordisk Investigational Site, Aschaffenburg
Novo Nordisk Investigational Site, Darmstadt
Novo Nordisk Investigational Site, Wiesbaden
Novo Nordisk Investigational Site, Flörsheim
Novo Nordisk Investigational Site, Vénissieux
Novo Nordisk Investigational Site, Joensuu
Novo Nordisk Investigational Site, Augsburg
Novo Nordisk Investigational Site, Wangen
Novo Nordisk Investigational Site, Hermaringen
Novo Nordisk Investigational Site, Corbeil-Essonnes
Novo Nordisk Investigational Site, Nanterre
Novo Nordisk Investigational Site, Pointe à Pitre
Novo Nordisk Investigational Site, Bad Mergentheim
Novo Nordisk Investigational Site, Kirkkonummi
Novo Nordisk Investigational Site, Turku
Novo Nordisk Investigational Site, Mougins
Novo Nordisk Investigational Site, Dresden
Novo Nordisk Investigational Site, Pirna
Novo Nordisk Investigational Site, Schkeuditz
Novo Nordisk Investigational Site, Dublin
Novo Nordisk Investigational Site, Dublin
Novo Nordisk Investigational Site, Waterford
Novo Nordisk Investigational Site, Delft
Novo Nordisk Investigational Site, Drachten
Novo Nordisk Investigational Site, Rijswijk
Novo Nordisk Investigational Site, Roelofarendsveen
Novo Nordisk Investigational Site, The Hague
Novo Nordisk Investigational Site, The Hague
Novo Nordisk Investigational Site, Vlodrop
Novo Nordisk Investigational Site, Zwijndrecht
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Palma de Mallorca
Novo Nordisk Investigational Site, Partida de Bacarot
Novo Nordisk Investigational Site, San Juan
Novo Nordisk Investigational Site, Aberdeen
Novo Nordisk Investigational Site, Bath
Novo Nordisk Investigational Site, Belfast
Novo Nordisk Investigational Site, Birmingham
Novo Nordisk Investigational Site, Bradford-on-Avon
Novo Nordisk Investigational Site, Guildford
Novo Nordisk Investigational Site, Hull
Novo Nordisk Investigational Site, Northampton
Novo Nordisk Investigational Site, Salford
Novo Nordisk Investigational Site, Swansea
Novo Nordisk Investigational Site, Trowbridge
Novo Nordisk Investigational Site, Trowbridge
Novo Nordisk Investigational Site, Wirral, Merseyside
Novo Nordisk Investigational Site, York
Lead Sponsor
Novo Nordisk A/S
INDUSTRY